Your browser doesn't support javascript.
loading
Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need.
Babulal, Ganesh M; Quiroz, Yakeel T; Albensi, Benedict C; Arenaza-Urquijo, Eider; Astell, Arlene J; Babiloni, Claudio; Bahar-Fuchs, Alex; Bell, Joanne; Bowman, Gene L; Brickman, Adam M; Chételat, Gaël; Ciro, Carrie; Cohen, Ann D; Dilworth-Anderson, Peggye; Dodge, Hiroko H; Dreux, Simone; Edland, Steven; Esbensen, Anna; Evered, Lisbeth; Ewers, Michael; Fargo, Keith N; Fortea, Juan; Gonzalez, Hector; Gustafson, Deborah R; Head, Elizabeth; Hendrix, James A; Hofer, Scott M; Johnson, Leigh A; Jutten, Roos; Kilborn, Kerry; Lanctôt, Krista L; Manly, Jennifer J; Martins, Ralph N; Mielke, Michelle M; Morris, Martha Clare; Murray, Melissa E; Oh, Esther S; Parra, Mario A; Rissman, Robert A; Roe, Catherine M; Santos, Octavio A; Scarmeas, Nikolaos; Schneider, Lon S; Schupf, Nicole; Sikkes, Sietske; Snyder, Heather M; Sohrabi, Hamid R; Stern, Yaakov; Strydom, Andre; Tang, Yi.
Afiliação
  • Babulal GM; Department of Neurology and Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA.
  • Quiroz YT; Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA; Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Albensi BC; Division of Neurodegenerative Disorders, St. Boniface Hospital Albrechtsen Research Centre, Winnipeg, Manitoba, Canada; Department of Pharmacology & Therapeutics, University of Manitoba, Winnipeg, Manitoba, Canada.
  • Arenaza-Urquijo E; Department of Radiology, Mayo Clinic, Rochester, MN, USA.
  • Astell AJ; Department of Occupational Sciences & Occupational Therapy, University of Toronto, CA; School of Psychology and Clinical Language Sciences, University of Reading, UK.
  • Babiloni C; Department of Physiology and Pharmacology "V. Erspamer", Sapienza University of Rome, Rome, Italy; Department of Neuroscience, IRCCS-Hospital San Raffaele Pisana of Rome and Cassino, Rome and Cassino, Italy.
  • Bahar-Fuchs A; Academic Unit for Psychiatry of Old Age, Department of Psychiatry, the University of Melbourne, Australia.
  • Bell J; Syneos Health, Wilmington, NC, USA.
  • Bowman GL; Nutrition and Brain Health Laboratory, Nestlé Institute of Health Sciences, Lausanne, Switzerland; Department of Neurology, Layton Aging & Alzheimer's Disease Center, Oregon Health & Science University, Portland, OR, USA.
  • Brickman AM; Taub Institute for Research in Alzheimer's Disease and the Aging Brain, The Gertrude H. Sergievsky Center, Department of Neurology, Columbia University, New York, NY, USA.
  • Chételat G; Inserm, Inserm UMR-S U1237, Université de Caen-Normandie, GIP Cyceron, Caen, France.
  • Ciro C; Department of Occupational Therapy Education, University of Kansas Medical Center, Kansas City, KS, USA.
  • Cohen AD; Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Dilworth-Anderson P; Gillings School of Global Public Health, University of North Carolina Chapel Hill, NC, USA.
  • Dodge HH; Department of Neurology, Layton Aging and Alzheimer's Disease Center, Oregon Health & Science University, Portland, OR, USA.
  • Dreux S; Undergraduate Program of History and Science, Harvard College, Cambridge, MA, USA.
  • Edland S; Department of Family Medicine and Public Health, University of California, San Diego, CA, USA.
  • Esbensen A; Department of Pediatrics, University of Cincinnati College of Medicine & Division of Developmental and Behavioral Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
  • Evered L; Melbourne Medical School, University of Melbourne, Australia.
  • Ewers M; Institute for Stroke and Dementia Research, Klinikum der Universität München, Munich, Germany.
  • Fargo KN; Medical & Scientific Relations, Alzheimer's Association, Chicago, IL, USA.
  • Fortea J; Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain; Barcelona Down Medical Center, Fundació Catalana de Síndrome de Down, Barcelona, Spain.
  • Gonzalez H; Department of Neurosciences and Shiley-Marcos Alzheimer's Disease Research Center, University of San Diego, CA, USA.
  • Gustafson DR; Department of Neurology, Section for NeuroEpidemiology, State University of New York - Downstate Medical Center, Brooklyn, NY, USA.
  • Head E; Sanders Brown Center on Aging, University of Kentucky, Lexington, KY, USA.
  • Hendrix JA; Medical & Scientific Relations, Alzheimer's Association, Chicago, IL, USA.
  • Hofer SM; Adult Development and Aging, University of Victoria, British Columbia, CA, USA.
  • Johnson LA; Department of Pharmacology & Neuroscience, University of North Texas Health Science Center, Fort Worth, TX, USA.
  • Jutten R; VU University Medical Center, Department of Neurology, Amsterdam Neuroscience, Amsterdam, the Netherlands.
  • Kilborn K; Department of Psychology, University of Glasgow, Glasgow, Scotland, UK.
  • Lanctôt KL; Sunnybrook Research Institute of Psychiatry and Pharmacology, University of Toronto, Toronto, ON, Canada.
  • Manly JJ; Taub Institute for Research in Alzheimer's Disease and the Aging Brain, The Gertrude H. Sergievsky Center, Department of Neurology, Columbia University, New York, NY, USA.
  • Martins RN; Aging and Alzheimer's Disease, School of Medical and Health Sciences, Edith Cowan University, Joondalup, Australia.
  • Mielke MM; Department of Epidemiology, Mayo Clinic, Rochester, MN, USA; Department of Neurology, Mayo Clinic, Rochester, MN, USA.
  • Morris MC; Department of Internal Medicine, Rush University, Chicago, IL, USA.
  • Murray ME; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
  • Oh ES; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Parra MA; School of Social Sciences, Department of Psychology, Heriot-Watt University, UK; Universidad Autónoma del Caribe, Barranquilla, Colombia; Neuroprogressive and Dementia Network, UK.
  • Rissman RA; Department of Neurosciences, University of California San Diego School of Medicine, CA, USA.
  • Roe CM; Department of Neurology and Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA.
  • Santos OA; Department of Psychiatry and Psychology, Mayo Clinic, Jacksonville, FL, USA.
  • Scarmeas N; Taub Institute for Research in Alzheimer's Disease and the Aging Brain, The Gertrude H. Sergievsky Center, Department of Neurology, Columbia University, New York, NY, USA; Aiginition Hospital, 1st Neurology Clinic, Department of Social Medicine, Psychiatry and Neurology, National and Kapodistrian Un
  • Schneider LS; Department of Psychiatry and The Behavioral Sciences, University of Southern California, CA, USA.
  • Schupf N; Department of Epidemiology, Mailman School of Public Health Columbia University, New York, NY, USA.
  • Sikkes S; Massachusetts General Hospital, Department of Neurology, Boston, MA, USA.
  • Snyder HM; Medical & Scientific Relations, Alzheimer's Association, Chicago, IL, USA.
  • Sohrabi HR; Aging and Alzheimer's Disease, School of Medical and Health Sciences, Edith Cowan University, Joondalup, Australia.
  • Stern Y; Department of Neurology, Columbia University, New York, NY, USA; Department of Psychiatry, Columbia University, New York, NY, USA.
  • Strydom A; Department of Forensic and Neurodevelopmental Science, Institute of Psychiatry Psychology and Neuroscience, King's College London, London, UK.
  • Tang Y; Department of Neurology, Xuan Wu Hospital, Capital Medical University, Beijing, China.
Alzheimers Dement ; 15(2): 292-312, 2019 02.
Article em En | MEDLINE | ID: mdl-30555031
ABSTRACT
Alzheimer's disease and related dementias (ADRDs) are a global crisis facing the aging population and society as a whole. With the numbers of people with ADRDs predicted to rise dramatically across the world, the scientific community can no longer neglect the need for research focusing on ADRDs among underrepresented ethnoracial diverse groups. The Alzheimer's Association International Society to Advance Alzheimer's Research and Treatment (ISTAART; alz.org/ISTAART) comprises a number of professional interest areas (PIAs), each focusing on a major scientific area associated with ADRDs. We leverage the expertise of the existing international cadre of ISTAART scientists and experts to synthesize a cross-PIA white paper that provides both a concise "state-of-the-science" report of ethnoracial factors across PIA foci and updated recommendations to address immediate needs to advance ADRD science across ethnoracial populations.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Etnicidade / Grupos Raciais / Disparidades em Assistência à Saúde / Doença de Alzheimer Tipo de estudo: Guideline / Prognostic_studies Limite: Aged / Humans Idioma: En Revista: Alzheimers Dement Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Etnicidade / Grupos Raciais / Disparidades em Assistência à Saúde / Doença de Alzheimer Tipo de estudo: Guideline / Prognostic_studies Limite: Aged / Humans Idioma: En Revista: Alzheimers Dement Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos